[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334122-105":59,"doc-detail-334122-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-significance-and-expression-of-slc35f6-in-bladder-urothelial-carcinoma-research-open-access","Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma - Research Open Access","","SLC35F6 negatively regulates outer mitochondrial membrane permeability and influences apoptotic signaling and cell proliferation, but its role in bladder cancer remains insufficiently defined. This study assesses SLC35F6 expression in 145 bladder cancer patients, evaluates its prognostic value, and examines associations with immune-related molecules within the tumor microenvironment. Bioinformatics and immunohistochemistry data were combined to analyze clinicopathologic correlations and predictive performance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-significance-and-expression-of-slc35f6-in-bladder-urothelial-carcinoma-research-open-access/334122/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-significance-and-expression-of-slc35f6-in-bladder-urothelial-carcinoma-research-open-access/334122.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SLC35F6’s proposed biological role in cancer based on the study background?","Question",{"text":112,"@type":113},"SLC35F6 negatively regulates outer mitochondrial membrane permeability and positively regulates apoptotic signaling pathways and cell population proliferation. The paper frames these mechanisms as potential drivers of bladder cancer behavior.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study measure SLC35F6 expression and relate it to patient outcomes?",{"text":117,"@type":113},"SLC35F6 expression was analyzed by immunohistochemistry (IHC) and complemented with bioinformatics. Prognostic impact was evaluated using Cox regression, Kaplan–Meier survival curves, and receiver operating characteristic analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical significance did elevated SLC35F6 expression show in bladder urothelial carcinoma?",{"text":121,"@type":113},"Both SLC35F6 mRNA and protein levels were higher in tumor tissue than in benign tissue. Patients with higher SLC35F6 protein expression had worse prognosis, and SLC35F6 was an independent risk factor alongside TNM stage and grade.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334122,1790575943,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Zhang et al. Diagnostic Pathology (2024) 19:150 [https://doi.org/10.1186/s13000-024-01582-2](https://doi.org/10.1186/s13000-024-01582-2)  \nDiagnostic Pathology  \nRESEARCH Open Access  \nClinical significance and expression  \nof SLC35F6 in bladder urothelial carcinoma  \nJinling Zhang1,2,3†, Siqi Liu1,2†, Meng Wu1,4†, Wenyu Shi1,4* and Yihong Cai1,4*  \nAbstract  \nBackground SLC35F6 negatively regulates outer mitochondrial membrane permeability and positively regulates apoptotic signaling pathways and cell population proliferation. The biological function of SLC35F6 in bladder cancer (BC) remains inadequately established. This study evaluates the expression and clinical significance of SLC35F6 in BC, assesses its prognostic value and explores its relationship with key immune-related molecules in the tumor microenvironment.  \nMethods Combining bioinformatics tools and immunohistochemistry (IHC) analysis, the expression of SLC35F6 was analyzed through IHC in the tissues of 145 BC patients treated at the Affiliated Hospital of Nantong University from 2004 to 2009. The relationship between SLC35F6 expression levels and significant clinicopathological factors was examined using the chi-square test. Prognostic values were analyzed using the COX regression model and the KaplanMeier survival curve. Analysis of the receiver operating characteristic curve was conducted to assess the predictive performance of SLC35F6 in BC patients.  \nResults The expression levels of both SLC35F6 mRNA and protein were elevated in BC tissue relative to benign tissue. Kaplan-Meier analysis indicated that patients exhibiting elevated SLC35F6 protein expression had a worse prognosis. Multivariate Cox regression analysis confirmed that SLC35F6, TNM stage and grade are independent risk factors for bladder cancer. SLC35F6, when analyzed alongside clinical pathological factors, enhances the accuracy of survival predictions for Bladder Urothelial Carcinoma (BLCA) patients.  \nConclusion SLC35F6 is upregulated in BC patients compared to normal individuals and is linked to a worse prognosis. SLC35F6 analyzed alongside clinical pathological factors can enhance the accuracy of survival predictions for BLCA patients, suggesting its potential value as a prognostic and predictive biomarker.  \nKeywords BLCA, SLC35F6, Immunohistochemistry, The tumor microenvironment (TME), Prognosis  \n†Jinling Zhang, Siqi Liu and Meng Wu have contributed equally to this work.  \n*Correspondence: Wenyu Shi [shiwenyu@hotmail.com](shiwenyu@hotmail.com)[ ](shiwenyu@hotmail.com)Yihong Cai [caiyihong@126.com](caiyihong@126.com)  \n1Department of Oncology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China  \n2Medical School of Nantong University, Nantong, Jiangsu 226001, China 3Clinical and Translational Research Center, Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China  \n4Department of Chemotherapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the ","cbCainvTTcn0jASv","https://ap.wps.com/l/cbCainvTTcn0jASv","pdf",1759539,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is SLC35F6’s proposed biological role in cancer based on the study background?\",\"answer\":\"SLC35F6 negatively regulates outer mitochondrial membrane permeability and positively regulates apoptotic signaling pathways and cell population proliferation. The paper frames these mechanisms as potential drivers of bladder cancer behavior.\"},{\"question\":\"How did the study measure SLC35F6 expression and relate it to patient outcomes?\",\"answer\":\"SLC35F6 expression was analyzed by immunohistochemistry (IHC) and complemented with bioinformatics. Prognostic impact was evaluated using Cox regression, Kaplan–Meier survival curves, and receiver operating characteristic analysis.\"},{\"question\":\"What clinical significance did elevated SLC35F6 expression show in bladder urothelial carcinoma?\",\"answer\":\"Both SLC35F6 mRNA and protein levels were higher in tumor tissue than in benign tissue. Patients with higher SLC35F6 protein expression had worse prognosis, and SLC35F6 was an independent risk factor alongside TNM stage and grade.\"}]","Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma - Research Open Access | PDF",1790005397,18]